首页 工具
登录
购物车

搜索结果

Search Results for " raf inhibitor 2 "

21

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T4194 Raf inhibitor 2

CID-25014542,CID 25014542,CID25014542

Raf MAPK
Raf inhibitor 2 (CID 25014542) 是新型 Raf 激酶抑制剂,IC50小于 1.0 μM,可用于癌症研究。
T11898 LXH254

Raf MAPK
LXH254 是B/C RAF 抑制剂。
T6525 GW 5074

GW5074,3-(3,5-二溴-4-羟基苯亚甲基)-5-碘-1,3-二氢吲哚-2-酮,Raf1 Kinase Inhibitor I

Apoptosis; Raf Apoptosis; MAPK
GW 5074 (Raf1 Kinase Inhibitor I) 是一种有效且特异性的 c-Raf 抑制剂,IC50值为 9 nM。 它对 JNK1/2/3、MEK1、MKK6/7、CDK1/2、c-Src、p38 MAP、VEGFR2 或 c-Fms 的活性没有影响。
T6296 RAF265

CHIR-265

Apoptosis; Raf; VEGFR; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
RAF265 (CHIR-265) 是一种 RAF/VEGFR2抑制剂。
T9585 GNE-9815

3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide

Raf MAPK
GNE-9815 (3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide) 是一种高激酶选择性 RAF 抑制剂,可用于通过联合治疗靶向 KRAS 突变癌症。
T40284 B-Raf IN 2

Raf MAPK
B-Raf IN 2, compound Ia, is a highly effective and specific inhibitor of BRAF. It exhibits significant potential for cancer research.
T6949 PLX7904

PB04

Raf MAPK
PLX7904 (PB04) 是一种有效且选择性的悖论破坏剂 RAF 抑制剂,可抑制突变 BRAF 黑色素瘤细胞中 ERK1/2 的激活。在表达突变体 RAS 的细胞中,对 BRAFV600E 的IC50值约为 5 nM。
T10157 Regorafénib N-oxyde (M2)

瑞戈非尼杂质 13

Raf; VEGFR; c-RET; PDGFR; c-Kit; Drug Metabolite Angiogenesis; Apoptosis; MAPK; Metabolism; Tyrosine Kinase/Adaptors
Regorafénib N-oxyde M2 是 Regorafenib 的活性代谢物。Regorafenib 是多靶点抑制剂,包括VEGFR1/2/3,PDGFRβ,Kit,RET 和 Raf-1 , IC50分别是 13/4.2/46,22,7,1.5 和 2.5 nM。
T22436 Takeda-6d

VEGFR Angiogenesis; Tyrosine Kinase/Adaptors
Takeda-6d 是一种新型、有效的 DFG-out RAF/血管内皮生长因子受体 2 (VEGFR2) 抑制剂,IC50 分别为 7.0 nM 和 2.2 nM。
T1792L Regorafenib monohydrate

Raf; VEGFR; c-RET; PDGFR; c-Kit; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Regorafenib monohydrate 是一种新型口服多激酶抑制剂,对VEGFR1/2/3、PDGFRβ、Kit、RET 和Raf-1的IC50分别为 13、4.2、46、22、7、1.5 和 2.5 nM。
T11224 Rineterkib

ERK-IN-1

ERK; Raf MAPK
Rineterkib (ERK-IN-1) 是口服有效的RAF 和ERK1/2的抑制剂,与 KRAS-突变型非小细胞肺癌、BRAF-突变型非小细胞肺癌、KRAS-突变型胰腺癌、KRAS -突变型结肠癌和 KRAS-突变型卵巢癌尤为相关。
T38511 AWL-II-38.3

Ephrin Receptor Tyrosine Kinase/Adaptors
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2].
T2624 OSI-930

OSI 930,噻尔非尼

Apoptosis; c-Fms; Raf; VEGFR; FLT; CSF-1R; Src; c-Kit Angiogenesis; Apoptosis; MAPK; Tyrosine Kinase/Adaptors
OSI-930 是 Kit,KDR 和 CSF-1R (c-Fms)的口服选择性抑制剂,IC50分别为 80 nM,9 nM 和 15 nM。它具有抗肿瘤活性,靶向肿瘤中的癌细胞增殖和血管生成。它还适度抑制 Flt-1,c-Raf 和 Lck,并且对 PDGFRα/β,Flt-3和 Abl 具有较弱的抑制活性。
T8402 Regorafenib Hydrochloride

瑞戈非尼盐酸盐,BAY73-4506 hydrochloride

Raf; VEGFR; c-RET; PDGFR; Autophagy Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors
Regorafenib Hydrochloride (BAY73-4506 hydrochloride) 是一种新型口服多激酶抑制剂,可抑制血管生成、基质和致癌受体酪氨酸激酶,具有强大的临床前抗肿瘤活性。它靶向作用于 VEGFR1/2/3、PDGFRβ、Kit、RET 和 Raf-1,IC50值分别为 13/4.2/46、22、7、1.5 和 2.5 nM。
T60933 B-Raf IN 7

B-Raf IN 7 (compound 6a) 是 B-Raf 的有效抑制剂,IC50值为 110.23 nM。B-Raf IN 7 对结肠癌细胞(HCT-116)、乳腺癌细胞 (MCF-7)、肝癌细胞 (HEPG-2)、人宫颈癌细胞 (Hela) 和人前列腺癌细胞 (PC-3) 具有抗肿瘤活性。其 IC50值分别为 7.50、9.87、10.57、11.63 和 12.83 μM。
T60727 B-Raf IN 8

B-Raf IN 8 (compound 7g) 是 B-Raf 的有效抑制剂 (IC50 = 70.65 nM)。B-Raf IN 8 显示出抗肿瘤活性,其对肝细胞癌 (HEPG-2)、结肠癌 (HCT-116),乳腺癌 (MCF-7) 和人前列腺癌 (PC-3) 细胞的 IC50值分别为9.78、13.78、18.5229.85 μM。
T36676 Rineterkib hydrochloride

Rineterkib hydrochloride (compound B) is an orally active RAF and ERK1/2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer[1]. ERK-IN-1 (compound B) (50, 75 mg/kg, p.o., qd/q2d, 27 days) treatment significantly reduces the tumor volume in the C...
T79572 MAPK-IN-2

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
MAPK-IN-2 (化合物3h)是一种携带抗肿瘤活性的高效MAPK抑制剂。它在多个癌细胞系中有效抑制了细胞增殖,并对MAPK途径表现出强大的抑制效果(EGFRWT IC50=281 nM, c-MET IC50=205 nM, B-RAFWT IC50=112 nM, CDK4/6 IC50=95和184 nM),对突变型EGFR和B-RAF亦展现出高效力(EGFRT790M IC50=69 nM, B-RAFV600E IC50=83 nM)。
T71163 Pimasertib HCl

Pimasertib HCl is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activati...
T64090 Regorafenib mesylate

Regorafenib (BAY 73-4506) mesylate 是一种口服具有活力的多靶点受体酪氨酸激酶 (tyrosine kinase) 抑制剂,能够抑制VEGFR1/2/3 (IC50=13/4.2/46 nM),PDGFRβ (IC50: 22 nM),Kit (IC50: 7 nM),RET (IC50: 1.5 nM) 和 Raf-1 (IC50: 2.5 nM)。Regorafenib mesylate 具有强大的抗肿瘤和抗血管生成作用。
T35578 Phosphatidylserines (sodium salt)

Phosphatidylserines (sodium salt),L-α-Phosphatidylserine

Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina. It is anionic and found mainly on the inner leaflet of the cell membrane. It is biosynthesized from phosphatidylcholine or phosphatidylethanolamine by phosphatidyl synthase 1 (PSS1) or PSS2, respectively, in the endoplasmic reticulum (ER) and can be reversibly converted back by the same enzymes. It can also be irre...

化合物

Raf inhibitor 2
Cat.No: T4194
Synonym: CID-25014542,CID 25014542,CID25014542
Target: Raf
LXH254
Cat.No: T11898
Synonym:
Target: Raf
GW 5074
Cat.No: T6525
Synonym: GW5074,3-(3,5-二溴-4-羟基苯亚甲基)-5-碘-1,3-二氢吲哚-2-酮,Raf1 Kinase Inhibitor I
Target: Apoptosis, Raf
RAF265
Cat.No: T6296
Synonym: CHIR-265
Target: Apoptosis, Raf, VEGFR, Autophagy
GNE-9815
Cat.No: T9585
Synonym: 3-(2-cyanopropan-2-yl)-N-[2-fluoro-4-methyl-5-(7-methyl-8-oxo-7,8-dihydropyrido[2,3-d]pyridazin-3-yl)phenyl]benzamide
Target: Raf
B-Raf IN 2
Cat.No: T40284
Synonym:
Target: Raf
PLX7904
Cat.No: T6949
Synonym: PB04
Target: Raf
Regorafénib N-oxyde (M2)
Cat.No: T10157
Synonym: 瑞戈非尼杂质 13
Target: Raf, VEGFR, c-RET, PDGFR, c-Kit, Drug Metabolite
Takeda-6d
Cat.No: T22436
Synonym:
Target: VEGFR
Regorafenib monohydrate
Cat.No: T1792L
Synonym:
Target: Raf, VEGFR, c-RET, PDGFR, c-Kit, Autophagy
Rineterkib
Cat.No: T11224
Synonym: ERK-IN-1
Target: ERK, Raf
AWL-II-38.3
Cat.No: T38511
Synonym:
Target: Ephrin Receptor
OSI-930
Cat.No: T2624
Synonym: OSI 930,噻尔非尼
Target: Apoptosis, c-Fms, Raf, VEGFR, FLT, CSF-1R, Src, c-Kit
Regorafenib Hydrochloride
Cat.No: T8402
Synonym: 瑞戈非尼盐酸盐,BAY73-4506 hydrochloride
Target: Raf, VEGFR, c-RET, PDGFR, Autophagy
B-Raf IN 7
Cat.No: T60933
Synonym:
Target:
B-Raf IN 8
Cat.No: T60727
Synonym:
Target:
Rineterkib hydrochloride
Cat.No: T36676
Synonym:
Target:
MAPK-IN-2
Cat.No: T79572
Synonym:
Target: EGFR
Pimasertib HCl
Cat.No: T71163
Synonym:
Target:
Regorafenib mesylate
Cat.No: T64090
Synonym:
Target:
Phosphatidylserines (sodium salt)
Cat.No: T35578
Synonym: Phosphatidylserines (sodium salt),L-α-Phosphatidylserine
Target:
Cat. No. Product Name Target Signaling Pathways
T16011 Manumycin A

Prostaglandin Receptor GPCR/G Protein; Immunology/Inflammation
Manumycin A is an antibiotic. Manumycin A induces apoptosis and exerts antitumor activity. Manumycin A inhibits exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling. Manumycin A acts as a selective, competitive inhibitor of
T35577 Phosphatidylserines (bovine)

Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina. It is anionic and found mainly on the inner leaflet of the cell membrane. It is biosynthesized from phosphatidylcholine or phosphatidylethanolamine by phosphatidyl synthase 1 (PSS1) or PSS2, respectively, in the endoplasmic reticulum and can be reversibly converted back by the same enzymes. It can also be irreversi...

天然产物

Manumycin A
Cat.No: T16011
Synonym:
Target: Prostaglandin Receptor
Phosphatidylserines (bovine)
Cat.No: T35577
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼